204 related articles for article (PubMed ID: 4080446)
1. Ornithine loading did not prevent induced hyperammonemia in a patient with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
Simell O; Mackenzie S; Clow CL; Scriver CR
Pediatr Res; 1985 Dec; 19(12):1283-7. PubMed ID: 4080446
[TBL] [Abstract][Full Text] [Related]
2. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: low creatine excretion and effect of citrulline, arginine, or ornithine supplement.
Dionisi Vici C; Bachmann C; Gambarara M; Colombo JP; Sabetta G
Pediatr Res; 1987 Sep; 22(3):364-7. PubMed ID: 3116497
[TBL] [Abstract][Full Text] [Related]
3. Hyperornithinemia, hyperammonemia, and homocitrullinuria associated with decreased carbamyl phosphate synthetase I activity.
Gatfield PD; Taller E; Wolfe DM; Haust MD
Pediatr Res; 1975 May; 9(5):488-97. PubMed ID: 166348
[TBL] [Abstract][Full Text] [Related]
4. Abnormal urinary excretion of polyamines in HHH syndrome (hyperornithinemia associated with hyperammonemia and homocitrullinuria).
Shimizu H; Maekawa K; Eto Y
Brain Dev; 1990; 12(5):533-5. PubMed ID: 2288388
[TBL] [Abstract][Full Text] [Related]
5. Episodic hyperammonemia in adult siblings with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome.
Tuchman M; Knopman DS; Shih VE
Arch Neurol; 1990 Oct; 47(10):1134-7. PubMed ID: 2222247
[TBL] [Abstract][Full Text] [Related]
6. Studies on a case of HHH-syndrome (hyperammonemia, hyperornithinemia, homocitrullinuria).
Hommes FA; Roesel RA; Metoki K; Hartlage PL; Dyken PR
Neuropediatrics; 1986 Feb; 17(1):48-52. PubMed ID: 3960284
[TBL] [Abstract][Full Text] [Related]
7. The hyperornithinemia, hyperammonemia, homocitrullinuria syndrome: an ornithine transport defect remediable with ornithine supplements.
Gordon BA; Gatfield DP; Haust MD
Clin Invest Med; 1987 Jul; 10(4):329-36. PubMed ID: 3652557
[TBL] [Abstract][Full Text] [Related]
8. Impairment of brain redox homeostasis caused by the major metabolites accumulating in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in vivo.
Viegas CM; Tonin AM; Zanatta A; Seminotti B; Busanello EN; Fernandes CG; Moura AP; Leipnitz G; Wajner M
Metab Brain Dis; 2012 Dec; 27(4):521-30. PubMed ID: 22798168
[TBL] [Abstract][Full Text] [Related]
9. Clinical, biochemical and ultrastructural study on the pathogenesis of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
Nakajima M; Ishii S; Mito T; Takeshita K; Takashima S; Takakura H; Inoue I; Saheki T; Akiyoshi H; Ichihara K
Brain Dev; 1988; 10(3):181-5. PubMed ID: 3407856
[TBL] [Abstract][Full Text] [Related]
10. [Hyperornithinemia, hyperammonemia and homocitrullinuria syndrome in a family].
Koike R; Fujimori K; Yuasa T; Miyatake T
Rinsho Shinkeigaku; 1987 Apr; 27(4):465-71. PubMed ID: 3621746
[No Abstract] [Full Text] [Related]
11. Hyperornithinemia, hyperammonemia, and homocitrullinuria. A new disorder of amino acid metabolism associated with myoclonic seizures and mental retardation.
Shih VE; Efron ML; Moser HW
Am J Dis Child; 1969 Jan; 117(1):83-92. PubMed ID: 5782534
[No Abstract] [Full Text] [Related]
12. Hyperornithinemia, hyperammonemia, homocitrullinuria (HHH) syndrome: presentation as acute liver disease with coagulopathy.
Smith L; Lambert MA; Brochu P; Jasmin G; Qureshi IA; Seidman EG
J Pediatr Gastroenterol Nutr; 1992 Nov; 15(4):431-6. PubMed ID: 1469525
[No Abstract] [Full Text] [Related]
13. Hyperornithinemia, hyperammonemia, and homocitrullinuria: case report and biochemical study.
Koike R; Fujimori K; Yuasa T; Miyatake T; Inoue I; Saheki T
Neurology; 1987 Nov; 37(11):1813-5. PubMed ID: 3670619
[TBL] [Abstract][Full Text] [Related]
14. Defective ornithine metabolism in cultured skin fibroblasts from patients with the syndrome of hyperornithinemia, hyperammonemia and homocitrullinuria.
Shih VE; Mandell R; Herzfeld A
Clin Chim Acta; 1982 Feb; 118(2-3):149-57. PubMed ID: 7055977
[TBL] [Abstract][Full Text] [Related]
15. Neonatal onset of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome with favorable outcome.
Zammarchi E; Ciani F; Pasquini E; Buonocore G; Shih VE; Donati MA
J Pediatr; 1997 Sep; 131(3):440-3. PubMed ID: 9329423
[TBL] [Abstract][Full Text] [Related]
16. Biochemical analysis of decreased ornithine transport activity in the liver mitochondria from patients with hyperornithinemia, hyperammonemia and homocitrullinuria.
Inoue I; Saheki T; Kayanuma K; Uono M; Nakajima M; Takeshita K; Koike R; Yuasa T; Miyatake T; Sakoda K
Biochim Biophys Acta; 1988 Jan; 964(1):90-5. PubMed ID: 3334877
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of intravenous lysine infusion on urea cycle metabolism.
Kato T; Sano M; Mizutani N
Eur J Pediatr; 1987 Jan; 146(1):56-8. PubMed ID: 3107993
[TBL] [Abstract][Full Text] [Related]
18. Ornithine methyl ester. An unusual metabolite encountered in the urine of patients with a urea cycle disorder characterized by hyperammonemia, hyperornithinemia and homocitrullinuria.
Gordon BA; Gatfield PD; Taller E
Clin Biochem; 1977 Apr; 10(2):78-82. PubMed ID: 862180
[TBL] [Abstract][Full Text] [Related]
19. Potential for the prenatal diagnosis of hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome.
Chadefaux B; Bonnefont JP; Rabier D; Shih VE; Saudubray JM; Kamoun P
Am J Med Genet; 1989 Feb; 32(2):264. PubMed ID: 2929667
[No Abstract] [Full Text] [Related]
20. [The dibasic amino acid metabolic disorders].
Shimizu H
Nihon Rinsho; 1992 Jul; 50(7):1555-60. PubMed ID: 1404883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
